Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 80425-0094

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 80425-0094). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 2

This is a graph showing the mean daytime heartburn scores for a study called RAB-USA-2, with three groups represented: placebo (with a sample size of 68), RAB 10mg, and RAB 20mg. The x-axis shows the study day, with scores at day 0, 14, 21, and 28. The heartburn scores range from 0 (none) to 4 (very severe), with 1 indicating sight, 2 indicating moderate, and 3 indicating severe.*

FDA Label Image

Figure 4

The image shows the Mean Daytime Heartburn Scores chart for the RAB-USA-3 study, with scores ranging from 0 to 4, where 0 means no heartburn and 4 means very severe heartburn. The scores are displayed for different days of the study (from day 0 to day 28) and for the placebo group. The number of participants is not available.*

FDA Label Image

Figure 5

FDA Label Image

Rabeprazole Sodium Dr Qty 30 Ndc 80425 0094

FDA Label Image

Rabeprazole Sodium Dr Qty 60 Ndc 80425 0094

This is a description of a medication, specifically Kabeprazole Sodium 20mg tablets that have been packed by a company called AAdvancedX X with a code RAB20922.*

FDA Label Image

Structure

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.